Aurobindo obtains FDA OK for generic Namenda
The medication is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.
Aurobindo has received the Food and Drug Administration’s clearance for memantine hydrochloride ER capsules, in dosage strengths of 7 mg, 14 mg, 21 mg, and 28 mg.
The medication is the generic of Forest Laboratories’ Namenda XR.
It is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.
Memantine hydrochloride ER capsules have a market value of roughly $46.6 million for the 12 months ended June 2021, according to IQVIA data.